Straight from the Desk
Syz the moment
Live feeds, charts, breaking stories, all day long.
- All
- equities
- United States
- Macroeconomics
- Food for Thoughts
- markets
- Central banks
- Fixed Income
- bitcoin
- Asia
- europe
- investing
- technical analysis
- geopolitics
- gold
- Crypto
- AI
- Commodities
- Technology
- nvidia
- ETF
- earnings
- Forex
- china
- Real Estate
- banking
- oil
- Volatility
- magnificent-7
- energy
- apple
- Alternatives
- emerging-markets
- switzerland
- tesla
- United Kingdom
- Middle East
- assetmanagement
- amazon
- russia
- ethereum
- microsoft
- ESG
- meta
- Industrial-production
- bankruptcy
- Healthcare
- Turkey
- Global Markets Outlook
- africa
- Market Outlook
- brics
US Tariffs 2.0: how can Switzerland secure a better deal?
Switzerland said it was confident about securing an early trade deal as it was willing to pledge nearly $150bn in US-bound investment (which is huge on relative terms). “We have nine million people in Switzerland, yet our investment pledge per capita is much more than what Japan or the EU have pledged. If we talk about a $40bn trade deficit, one has to put that [in] perspective,” said Rahul Sahgal, chief executive of the Swiss-American Chamber of Commerce. Let’s also keep in mind that we are also a huge investor in the US, with Nestlé, Roche and Novartis employing thousands of Americans. Gold exports — often transiting through Switzerland for refining or trade — are largely responsible for the country’s trade imbalance with the US. Yet both gold and pharmaceutical products are exempt from Trump’s “reciprocal tariffs. Pharmaceutical sector could be the tipping point: Switzerland’s pharma sector sends about 60% of its exports to the US. Novartis and Roche’s US subsidiary Genentech were among the pharmaceutical companies that received letters from the Trump administration this week demanding that they lower drug prices. Swiss watchmaker Breitling’s CEO Georges Kern said his country was being “held hostage” by the pharmaceutical industry that had irritated Trump. Source: FT
Since 1985, Nasdaq 100 has a rough start to August, with double-dips ultimately resulting in a W-shaped recovery into end-of-month.
Might take a little longer (release of CPI mid-month) if downside persists and before recovery ensues in 2025. Source: Seth Golden
Ever wonder why S&P 500 concentration is hitting record highs?
Investors are piling into mega tech for one big reason: huge free cash flow generation and strong net income growth! ➡️ The net income gap between the top 10 giants and the rest keeps widening. Without the top 6, S&P 500 earnings growth is flatlining. ⚠️ Meanwhile, around 40% of Russell 2000 small caps aren't even profitable. Source: FT thru Andrea Lisi
US recession odds have fallen to an all-time low of 11%.
Source: Kalshi
Trump’s tariff deadline is near.
Here’s a look at countries that have a deal — and those that don’t. source: CNBC
As expected, the fed leaves rates unchanged despite some of the positive developments observed on the inflations side (see below Inflation surprise index versus Fed Funds rate).
We note that this decision was met with opposition from Governors Michelle Bowman and Chris Waller, both of whom have advocated for the Fed to start easing. This is the first time since 1993 that multiple governors cast no votes on rate decision. Source: zerohedge
Will we see the typical post-Powell sell-off again today? It's a tradition.
Source: Bespoke @bespokeinvest
Investing with intelligence
Our latest research, commentary and market outlooks

